The Medicines Company Strengthens its Perioperative Care Franchise via Deals with Incline Therapeutics and BMS
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 1 (Table of Contents)
Published: 7 Jan-2013
DOI: 10.3833/pdr.v2013.i1.1868 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
The Medicines Company (TMC) has agreed to acquire Incline Therapeutics, which is pursuing the development of Ionsys® (fentanyl iontophoretic transdermal system), a needleless, patient-controlled analgesia device for the short-term management of acute postoperative pain...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS